Understanding and management of anti-N-methyl-D-aspartate receptor encephalitis from a child psychiatry perspective: report of five cases

References

• Alvarez, R. V., Palmer, C., Czaja, A. S., Peyton, C., Silver, G., Traube, C., Mourani, P. M., & Kaufman, J. (2018, April). Delirium is a common and early finding in patients in the pediatric cardiac intensive care unit. The Journal of Pediatrics, 195(April 2018), 206–212. Epub 2018 Feb 13. PMID: 29395177 https://doi.org/https://doi.org/10.1016/j.jpeds.2017.11.064
   PubMedGoogle Scholar
• Beck, A. T., & Steer, R. A. (1984). Internal consistencies of the original and revised beck depression inventory. Journal of Clinical Psychology, 40(6), 1365–1367. https://doi.org/https://doi.org/10.1002/1097-4679(198411)40:6<1365::AID-JCLP2270400615>3.0.CO;2-D
   PubMedGoogle Scholar
• Cortes, C., & Manterola, C. (2020, November). Behavioral alterations associated with levetiracetam in pediatric epilepsy. Epilepsy & Behavior, 112(November 2020), 107472. Epub 2020 Sep 25. PMID: 33181889 https://doi.org/https://doi.org/10.1016/j.yebeh.2020.107472
   PubMedGoogle Scholar
• Creten, C., van der Zwaan, S., Blankespoor, R. J., Maatkamp, A., Nicolai, J., van Os, J., & Schieveld, J. N. (2011, July 2). Late onset autism and anti-NMDA-receptor encephalitis. The Lancet, 378(9785), 98. PMID: 21724038 https://doi.org/https://doi.org/10.1016/S0140-6736(11)60548-5
   PubMedGoogle Scholar
• Dalmau, J., & Bataller, L. (2007, October). Encefalitis límbica: Los nuevos antígenos y propuesta de una clasificación clinicoinmunológica con implicaciones terapéuticas [Limbic encephalitis: The new cell membrane antigens and a proposal of clinical-immunological classification with therapeutic implications]. Neurologia, 22(8), 526–537 https://pubmed.ncbi.nlm.nih.gov/18000762/. Spanish. PMID: 18000762
   PubMedGoogle Scholar
• Dalmau, J., Armangué, T., Planagumà, J., Radosevic, M., Mannara, F., Leypoldt, F., Geis, C., Lancaster, E., Titulaer, M. J., Rosenfeld, M. R., & Graus, F. (2019, November). An update on anti-NMDA receptor encephalitis for neurologists and psychiatrists: Mechanisms and models. The Lancet Neurology, 18(11), 1045–1057. Epub 2019 Jul 17. PMID: 31326280 https://doi.org/https://doi.org/10.1016/S1474-4422(19)30244-3
   PubMedGoogle Scholar
• Florance, N. R., Davis, R. L., Lam, C., Szperka, C., Zhou, L., Ahmad, S., Campen, C. J., Moss, H., Peter, N., Gleichman, A. J., Glaser, C. A., Lynch, D. R., Rosenfeld, M. R., & Dalmau, J. (2009, July). Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis in children and adolescents. Annals of Neurology, 66(1), 11–18. PMID: 19670433; PMCID: PMC2826225 https://doi.org/https://doi.org/10.1002/ana.21756
   PubMedGoogle Scholar
• Giné Servén, E., Boix Quintana, E., Martínez Ramírez, M., Guanyabens Buscà, N., Muriana Batiste, D., Guasp, M., Torres Rivas, C., Davi Loscos, E., & Casado Ruiz, V. (2021, February). Cycloid psychosis as a psychiatric expression of anti-NMDAR encephalitis. A systematic review of case reports accomplished with the authors’ cooperation. Brain and Behavior, 11(2), e01980. Epub 2020 Dec 3. PMID: 33270360; PMCID: PMC7882155 https://doi.org/https://doi.org/10.1002/brb3.1980
   PubMedGoogle Scholar
• Gough, J. L., Coebergh, J., Chandra, B., & Nilforooshan, R. (2016). Electroconvulsive therapy and/or plasmapheresis in auto-immune encephalitis? World Journal of Clinical Cases, 4(8), 223–228. https://doi.org/https://doi.org/10.12998/wjcc.v4.i8.223
   PubMedGoogle Scholar
• Gurrera, R. J. (2019, May). Recognizing psychiatric presentations of anti-NMDA receptor encephalitis in children and adolescents: A synthesis of published reports. Psychiatry and Clinical Neurosciences, 73(5), 262–268. Epub 2019 Feb 21. PMID: 30653785. https://doi.org/https://doi.org/10.1111/pcn.12821
   PubMedGoogle Scholar
• Hedges, D., Jeppson, K., & Whitehead, P. (2003, July). Antipsychotic medication and seizures: A review. Drugs of Today, 39(7), 551–557. PMID: 12973403 https://doi.org/https://doi.org/10.1358/dot.2003.39.7.799445
   PubMedGoogle Scholar
• Jeon, S. M., Park, S., Kim, D., & Kwon, J. W. (2021, March). Risk of seizures associated with antipsychotic treatment in pediatrics with psychiatric disorders: A nested case-control study in Korea. European Child & Adolescent Psychiatry, 30(3), 391–399. Epub 2020 Apr 7. PMID: 32266577 https://doi.org/https://doi.org/10.1007/s00787-020-01525-4
   PubMedGoogle Scholar
• Kaufman, J., Birmaher, B., Brent, D., Rao, U., Flynn, C., Moreci, P., Williamson, D., & Ryan, N. (1997). Schedule for affective disorders and schizophrenia for school age children-present and lifetime version (K-SADS-PL): Initial reliability and validity data. Journal of American of Academy Child and Adolescent Psychiatry, 36(7), 980–988. https://doi.org/https://doi.org/10.1097/00004583-199707000-00021
   PubMedGoogle Scholar
• Kay, S. R., Fiszbein, A., & Opler, L. A. (1987). The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophrenia Bulletin, 13(2), 261–276. https://doi.org/https://doi.org/10.1093/schbul/13.2.261
   PubMedGoogle Scholar
• Kayser, M. S., & Dalmau, J. (2011). Anti-NMDA receptor encephalitis in psychiatry. Current Psychiatry Reviews, 7 (3) , 189–193. PMID: 24729779; PMCID: PMC3983958. https://doi.org/https://doi.org/10.2174/157340011797183184
   PubMedGoogle Scholar
• Kuppuswamy, P. S., Takala, C. R., & Sola, C. L. (2014, July-August). Management of psychiatric symptoms in anti-NMDAR encephalitis: A case series, literature review and future directions. General Hospital Psychiatry, 36 (4) , 388–391. Epub 2014 Mar 5. PMID: 24731834 https://doi.org/https://doi.org/10.1016/j.genhosppsych.2014.02.010
   PubMedGoogle Scholar
• Lertxundi, U., Hernandez, R., Medrano, J., Domingo-Echaburu, S., García, M., & Aguirre, C. (2013, March). Antipsychotics and seizures: Higher risk with atypicals? Seizure, 22(2), Epub 2012 Nov 10. PMID: 23146619. 141–143. https://doi.org/https://doi.org/10.1016/j.seizure.2012.10.009
   PubMedGoogle Scholar
• Marzullo, L. R. (2014, April). Pharmacologic management of the agitated child. Pediatric Emergency Care, 30(4), 269–275. quiz 276-8PMID: 24694885 https://doi.org/https://doi.org/10.1097/PEC.0000000000000112
   PubMedGoogle Scholar
• Muñoz-Lopetegi, A., Graus, F., Dalmau, J., & Santamaria, J. (2020, December). Sleep disorders in autoimmune encephalitis. The Lancet Neurology, 19(12), 1010–1022. PMID: 33212053 https://doi.org/https://doi.org/10.1016/S1474-4422(20)30341-0
   PubMedGoogle Scholar
• Nguyen, A. V., Young, K. A., & Bourgeois, J. A. (2020 June 18). Psychiatric prodrome in anti-NMDAR-associated encephalopathy: Clinical and Pathophysiologic considerations. The Primary Care Companion For CNS Disorders, 22(3), 19r02563. PMID: 32569449 https://doi.org/https://doi.org/10.4088/PCC.19r02563
   PubMedGoogle Scholar
• Overall, J. E., & Gorham, D. (1962). The brief psychiatric rating scale. Psychological Reports, 10(3), 789–812. https://doi.org/https://doi.org/10.2466/pr0.1962.10.3.799
   Google Scholar
• Pandharipande, P., Shintani, A., Peterson, J., Pun, B. T., Wilkinson, G. R., Dittus, R. S., Bernard, G. R., & Ely, E. W. (2006, January). Lorazepam is an independent risk factor for transitioning to delirium in intensive care unit patients. Anesthesiology, 104(1), 21–26. PMID: 16394685. https://doi.org/https://doi.org/10.1097/00000542-200601000-00005
   PubMedGoogle Scholar
• Schieveld, J. N. M., Strik, J. J. M. H., van Kraaij, S., & Nicolai, J. (2019). Psychiatric manifestations and psychopharmacology of autoimmune encephalitis: A multidisciplinary approach. Handbook of Clinical Neurology, 165(2019), 285–307. PMID: 31727218. https://doi.org/https://doi.org/10.1016/B978-0-444-64012-3.00017-4
   PubMedGoogle Scholar
• Spielberger, C. D., Gorsuch, R. L., & Lushenene, R. E. (1970). STAI Manual: For the State-Trait Anxiety Inventory. In Self-Evaluation Questionnaire (1st ed., pp. 1–10). Consulting Psychologists Press.
   Google Scholar
• Swayne, A., Warren, N., Prain, K., Gillis, D., O’Gorman, C., Tsang, B. K., Muller, C., Broadley, S., Adam, R. J., McCombe, P., Wong, R. C., & Blum, S. (2021 February 22). An Australian state-based cohort study of autoimmune encephalitis cases detailing clinical presentation, investigation results, and response to therapy. Frontiers in Neurology, 12(2021), 607773. PMID: 33692738; PMCID: PMC7937705 https://doi.org/https://doi.org/10.3389/fneur.2021.607773
   PubMedGoogle Scholar
• Titulaer, M. J., McCracken, L., Gabilondo, I., Armangué, T., Glaser, C., Iizuka, T., Honig, L. S., Benseler, S. M., Kawachi, I., Martinez-Hernandez, E., Aguilar, E., Gresa-Arribas, N., Ryan-Florance, N., Torrents, A., Saiz, A., Rosenfeld, M. R., Balice-Gordon, R., Graus, F., & Dalmau, J. (2013, February). Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: An observational cohort study. Lancet Neurology, 12(2), 157–165. Epub 2013 Jan 3. PMID: 23290630; PMCID: PMC3563251 https://doi.org/https://doi.org/10.1016/S1474-4422(12)70310-1
   PubMedGoogle Scholar